CAS No.:124858-35-1
Name: Nadifloxacin
Details Introduction
TOXICITY DATA with REFERENCE:
SAFETY PROFILE:
Standards and Recommendations:Following a single topical application of 10gm nadifloxacin 1% cream to normal human back skin, the highest plasma concentration was determined to be 107ng./ml with an elimination half-life of 19.4 hours. Approximately 0.09% of the administered dose was excreted in the urine over 48 hours post- dosing. The plasma concentration reached a steady state on Day 5 of repeated administration study when nadifloxacin 1% cream was applied at 5 gm twice daily to normal healthy individuals for a period of 7 days. The plasma concentration reached a peak of 4.1 ng/ml at 8 hours post-final dosing with an elimination half-Life of 23.2 hours. The urinary excretion rate reached 0.16% on Day 7.
Related Searches
Related Suppliers
- Dayang Chem (Hangzhou) Co.,Ltd.
- Afine Chemicals Limited
- Hangzhou JINLAN Pharm-Drugs Technology Co., Ltd
- Beijing Mediking Biopharm Co., Ltd.
- CHANGZHOU YABANG-QH PHARMACHEM CO., LTD.
- Shandong Loyal Chemical industrial Co.,Ltd
- Hangzhou Dawn Ray Pharmaceutical Co.,Ltd
- Shijiazhuang Sdyano Fine Chemical Co., Ltd
- Manus Aktteva Biopharma LLP
- AXXORA, LLC
- Shanghai agrotree chemical co.,ltd.
- Hubei Hengluyuang Technology Co.,Ltd
- Jinan Hongfangde Pharmatech Co.LTD

Other Product
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (4S,6R)-6-{2-[(2-hydroxy-ethyl)-(4-methoxy-benzenesulfonyl)-amino]-ethoxy}-4-isopropyl-5,6-dihydro-4H-pyran-2-carboxylic acid allyl ester
- [1,4'-Bipiperidine]-1'-carboxylic acid, 4-(1H-indol-7-yl)-, ethyl ester
- 1,3,5-Tris(4-acetamidophenyl)penta-1,5-dione
- 1,5-Bis(3-aminophenyl)-3-(4-N,N-di-methylaminophenyl)penta-1,5-dione
- 1,5-Bis(4-acetamidophenyl)-3-phenylpenta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-(4-acetamido-phenyl)penta-1,5-dione
- 1,5-Bis(4-aminophenyl)-3-phenylpenta-1,5-dione
